-
Spyre Therapeutics (NASDAQ:SYRE) Given "Outperform" Rating at Wedbush
来源: Buzz FX / 13 1月 2025 18:30:16 America/New_York
Spyre Therapeutics (NASDAQ:SYRE) Given "Outperform" Rating at Wedbush Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Spyre Therapeutics ( NASDAQ:SYRE - Get Free Report ) 's stock had its "outperform" rating restated
Read more...